Previous 10 | Next 10 |
Calyxt to Present at the H.C. Wainwright 24th Annual Global Investment Conference PR Newswire ROSEVILLE, Minn. , Sept. 7, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that Michae...
Calyxt, Inc. (CLXT) Q2 2022 Earnings Conference Call August 4, 2022 16:30 ET Company Participants Bill Koschak - Chief Financial Officer Michael Carr - President and Chief Executive Officer Conference Call Participants Bobby Burleson - Canaccord Amit ...
The following slide deck was published by Calyxt, Inc. in conjunction with their 2022 Q2 earnings call. For further details see: Calyxt, Inc. 2022 Q2 - Results - Earnings Call Presentation
Calyxt press release ( NASDAQ: CLXT ): Q2 Non-GAAP EPS of -$0.36 (vs. -$0.80 Y/Y). Revenue of $1.35M (-87.9% Y/Y). For further details see: Calyxt Q2 Non-GAAP EPS of -$0.36, revenue of $1.35M
Calyxt Reports Second Quarter 2022 Financial Results and Provides Corporate Update PR Newswire Evaluated nine new customer demand-driven plant-based chemistries in the quarter, bringing cumulative chemistries evaluated for development to 95, of these 31 meet Calyxt's t...
Calyxt to Present at the Canaccord Genuity 42nd Annual Growth Conference PR Newswire ROSEVILLE, Minn. , July 28, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that Michael A. Carr , ...
Calyxt to Host Second Quarter 2022 Financial Results Conference Call and Webcast on Thursday, August 4, 2022, at 4:30 p.m. Eastern Time PR Newswire ROSEVILLE, Minn. , July 21, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthet...
Calyxt to Present at Upcoming Conferences PR Newswire ROSEVILLE, Minn. , May 17, 2022 /PRNewswire/ -- Calyxt , Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that management will participate in the following upco...
Calyxt, Inc. (CLXT) Q1 2022 Earnings Conference Call May 5, 2022 16:30 ET Company Participants Bill Koschak - Chief Financial Officer Michael Carr - President and Chief Executive Officer Conference Call Participants Bobby Burleson - Canaccord Amit Dayal - H.C. Wainwright Brian Wright - ROTH C...
Calyxt press release (NASDAQ:CLXT): Q1 Non-GAAP EPS of -$0.14 beats by $0.03. Revenue of $0.03M (-99.3% Y/Y) misses by $0.35M. Shares +4%. For further details see: Calyxt Non-GAAP EPS of -$0.14 beats by $0.03, revenue of $0.03M misses by $0.35M
News, Short Squeeze, Breakout and More Instantly...
Shares of Calyxt, Inc. (NASDAQ: CLXT) traded at a new 52-week high today and are currently trading at $5.4. So far today, approximately 55,181 shares have been exchanged, as compared to an average 30-day volume of 89,248 shares. Calyxt, Inc., a synthetic biology company, engages in delivering...
Calyxt Announces Stockholder Approval of Merger With Cibus PR Newswire -- Calyxt Announces 1-for-5 Reverse Stock Split of Common Stock -- ROSEVILLE, Minn. , May 19, 2023 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT) ("Calyxt" or the "Company") today announc...
Calyxt Reports First Quarter 2023 Financial Results and Provides Corporate Update PR Newswire —P roposed merger with Cibus Global Expected to Close in Q2 2023 — —1-for-10 reverse stock split executed— —Current customer...